Collaborative Fund

Collaborative Fund is the New York firm Craig Shapiro built around the idea that the next generation of meaningful businesses would be defined as much by their values as by their unit economics. The fund, which manages roughly $1 billion in assets, sits across consumer, climate, food, and health, and the through-line across the categories is a thesis that mission-aligned companies will compound advantages in talent, capital, and customers over time. Health is one of several verticals rather than the firm’s primary identity, and the fund’s positioning in healthcare reflects that: Collaborative is most active in consumer health and digital health, where the firm’s brand and consumer expertise create a tailwind. For founders building values-led consumer health and wellness companies, Collaborative is one of the more distinctive partners in the early-stage market.

The thesis is that culture, values, and mission are durable competitive advantages, and that the most interesting businesses of the next decade will integrate those advantages into how they hire, build, and sell. Within wellness and consumer health and digital health, the firm targets companies whose brand and product reflect a coherent values position and whose customers are willing to pay a premium for it. Collaborative is not a clinical-first investor; the firm is comfortable with regulated healthcare categories but does not specialize in payer contracting, health system sales, or therapeutics development. Founders should expect a partner whose first questions are about the brand, the customer, and the cultural moment the company is responding to, with the clinical and regulatory architecture treated as supporting rather than primary.

Collaborative’s portfolio across consumer, climate, food, and health includes companies that have built meaningful consumer brands while sustaining mission alignment. In health and wellness specifically, the firm has been active in companies that integrate consumer, food, and health categories, often at the boundaries between products that are formally classified as health and products that simply make their consumers healthier. The pattern is companies that lead with brand and values, that have credible early consumer demand, and that have a path to scale that does not depend exclusively on traditional healthcare distribution channels.

Check sizes are in the $250,000 to $1 million range at Seed and Series A, which positions the firm as an early conviction investor rather than a lead in larger priced rounds. Collaborative is comfortable co-investing alongside both consumer-specialist firms and healthcare-specialist firms, and the firm’s capital stack positioning is that of a thesis-aligned early backer who brings brand and consumer reach rather than a check large enough to anchor a round. Founders raising a $3 million seed will often include Collaborative as a partial check alongside a larger lead, and the firm’s brand can help attract additional investors and operating talent into a round.

Craig Shapiro is the founder and the public face of the firm, and the firm has historically reflected his personal investing posture. Decision-making is partner-led and conviction-driven, and the firm is known for forming a view quickly when the brand and mission alignment are clear. Founders should expect meetings to focus on the founders themselves, the cultural insight behind the company, and the long-term values position, rather than on a quantitative deep-dive into financial models. The firm’s communication style is direct, founder-respecting, and brand-aware.

The most reliable path into Collaborative is a warm introduction from a portfolio founder, particularly one whose company sits in an adjacent consumer or wellness category. Introductions from consumer brand operators and from journalists or thinkers in the firm’s intellectual network also tend to land. Cold outreach is read when it is values-coherent and brand-credible, but the firm’s preferred entry point is a founder reference. Communication after first contact is fast when the thesis fits and politely conclusive when it does not.

Approach Collaborative when you are building a values-led consumer or wellness company with a credible brand thesis and an early consumer demand signal, and when you want an early partner who will help shape brand and culture. Do not approach when you are building a clinical, therapeutics, or health-system-facing company, when your differentiation is technical rather than brand-led, or when you need a lead investor with a $5 million-plus check. Collaborative is a focused, brand-forward early backer for the founders building the next generation of mission-aligned consumer health.